Volume | 16 887 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 3,5694 | Bas Haut |
|||||
Minimum Bas | 3,47 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Tenax Therapeutics Inc | TENX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
3,55 | 3,47 | 3,5694 | 3,48 | 3,60 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
163 | 16 887 | US$ 3,53 | US$ 59 563 | - | 3,47 - 61,152 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:39:37 | 4 | US$ 3,57 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
1,04M | 298,28k | - | 0 | -7,71M | -25,85 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Tenax Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
09/4/2024 | 14:30 | GlobeNewswire Inc. | Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the.. |
28/3/2024 | 13:30 | GlobeNewswire Inc. | Tenax Therapeutics Provides Business and Clinical.. |
12/3/2024 | 13:30 | GlobeNewswire Inc. | Tenax Therapeutics to Present at the 36th Annual Roth.. |
29/2/2024 | 15:00 | GlobeNewswire Inc. | Tenax Therapeutics Announces Oral Presentation of.. |
26/2/2024 | 22:31 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
23/2/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 22:01 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
20/2/2024 | 14:33 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 14:30 | GlobeNewswire Inc. | Tenax Therapeutics Announces Global License Amendment that.. |
16/2/2024 | 17:28 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
16/2/2024 | 01:36 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
12/2/2024 | 22:46 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Tenax Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Tenax Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 3,58 | 3,7778 | 3,47 | 3,57 | 12 679 | -0,10 | -2,79% |
1 mois | 4,15 | 4,249 | 3,47 | 3,81 | 32 532 | -0,67 | -16,14% |
3 mois | 11,49 | 21,4599 | 3,47 | 8,62 | 371 890 | -8,01 | -69,71% |
6 mois | 22,40 | 61,152 | 3,47 | 43,65 | 3 757 963 | -18,92 | -84,46% |
1 an | 25,92 | 61,152 | 3,47 | 41,16 | 2 179 207 | -22,44 | -86,57% |
3 ans | 3 024,00 | 3 680,00 | 3,47 | 157,92 | 1 571 513 | -3 020,52 | -99,88% |
5 ans | 2 624,00 | 5 888,00 | 3,47 | 1 057,02 | 1 362 228 | -2 620,52 | -99,87% |